Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
Therapeutic effects of systemic administration of chaperone αB-crystallin associated with binding proinflammatory plasma proteins.
Associations Between Fatigue and Disability, Functional Mobility, Depression, and Quality of Life in People with Multiple Sclerosis.
Neuroimmunology: Phase II trial demonstrates efficacy of erythropoietin in optic neuritis.
Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients.
Mutation Analysis of Gap Junction Protein Beta 1 and Genotype-Phenotype Correlation in X-linked Charcot-Marie-Tooth Disease in Chinese Patients.
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
European Commission approves Genzyme’s multiple sclerosis treatment Lemtrada™ (alemtuzumab)
Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.
Overview of the immune system.
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group.
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.
Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor.
Movement and structure of mitochondria in oligodendrocytes and their myelin sheaths.
Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.
Synthetic Biologics announces issuance of U.S. patent covering combination of estriol and Copaxone® for multiple sclerosis
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
Multiple sclerosis and risk of attempted and completed suicide - a cohort study.
Effect of vitamin D on MS activity by disease-modifying therapy class.
Mast cell inflammasome activity in the meninges regulates EAE disease severity.
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
Acute disseminated encephalomyelitis in 228 patients: A retrospective, multicenter US study.
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
The use of hematopoietic stem cells in autoimmune diseases.

Pages